| 2023年年报 | 2022年年报 | |
|---|---|---|
| 营业收入(元) | ||
| 医药代理(元) | 134,021,866.34 | 117,623,722.80 |
| 医药制造(元) | 4,048,645,801.47 | 4,403,349,342.39 |
| 营业成本(元) | ||
| 医药代理(元) | 81,687,853.12 | 71,880,875.33 |
| 医药制造(元) | 1,481,877,500.76 | 1,526,124,235.66 |
| 毛利(元) | ||
| 医药代理(元) | 52,334,013.22 | 45,742,847.47 |
| 医药制造(元) | 2,566,768,300.71 | 2,877,225,106.73 |
| 毛利率(%) | ||
| 医药代理(%) | 39.05 | 38.89 |
| 医药制造(%) | 63.40 | 65.34 |
| 收入构成(%) | ||
| 医药代理(%) | 3.20 | 2.60 |
| 医药制造(%) | 96.80 | 97.40 |
| 毛利构成(%) | ||
| 医药代理(%) | 2.00 | 1.56 |
| 医药制造(%) | 98.00 | 98.44 |